summary
Introduced
03/29/2022
03/29/2022
In Committee
11/30/2022
11/30/2022
Crossed Over
Passed
Dead
12/31/2022
12/31/2022
Introduced Session
134th General Assembly (2021-2022)
Bill Summary
To enact sections 3902.62 and 5164.13 of the Revised Code to require health benefit plan and Medicaid program coverage of biomarker testing.
AI Summary
This bill requires health benefit plans and the Medicaid program in Ohio to cover biomarker testing for the purposes of diagnosis, treatment, and ongoing monitoring of diseases and conditions. Biomarker refers to a measurable indicator of biological processes, and biomarker testing includes analyzing tissue, blood, or other biospecimens. The coverage is required when the test is supported by evidence such as FDA approval, national coverage determinations, clinical practice guidelines, or consensus statements. The bill also outlines the appeals process for coverage determinations.
Committee Categories
Business and Industry
Sponsors (14)
Thomas West (D)*,
Andrea White (R)*,
Rodney Creech (R),
Jon Cross (R),
Kyle Koehler (R),
Laura Lanese (R),
Michele Lepore-Hagan (D),
Mary Lightbody (D),
Scott Lipps (R),
Beth Liston (D),
Susan Manchester (R),
Jean Schmidt (R),
Michael Sheehy (D),
Tom Young (R),
Last Action
Informally passed (on 12/14/2022)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...